DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

11.83 -0.36 (-2.95%)

REAL-TIME: Last trade at

Extended Hours: $11.83 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

BCRX $11.83 -2.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.19
Previous Close $12.19
Daily Range $11.83 - $12.69
52-Week Range $4.55 - $14.62
Market Cap $848.9M
P/E Ratio -19.35
Dividend (Yield) $0.00 (0.0%)
Volume 1,262,095
Average Daily Volume 1,670,902
Current FY EPS -$0.84





BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website:

News & Commentary

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

The Ebola stocks: Effect of an outbreak

The Ebola stocks: The outbreak effect

New Ebola Fears in NYC Make Major Ebola Stock Waves

Ebola Stock Fallout Severe on Monday

Healthcare Stocks in Focus on Ebola Fears - Analyst Blog

Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

5 Companies That Could Develop An Enterovirus Treatment

5 Companies That Could Develop An Enterovirus Treatment

See More BCRX News...

BCRX's Top Competitors

BCRX $11.83 (-2.95%)
Current stock: BCRX
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB